One fact we can safely predict in 2017, is that value-based care models are not going anywhere. For insurers and practitioners to successfully navigate these new models is to focus on these four key areas: population health and disease management, clinical decision support technology, care
Opioid abuse continues to rise in the United States, affecting not only the individual – but also their family, friends, employers, and communities. According to the Centers for Disease Control and Prevention, nearly 2 million Americans currently abuse prescription opioids, causing an estimated 44 people to die every day, tallying an unthinkable 16,000 opioid related deaths each year. Furthermore, this number does not account for the individuals that move on from prescription drugs to more dangerous street drugs that so often times result in additional overdoses and deaths.
Employer-sponsored medical plans are expected to see an unparalleled increase globally in 2017 despite lowering inflation rates according to a new Aon report. While inflation rates dip slightly from 2.9 to 2.8 in 2017, medical plans are projected to increase from 8.1 to 8.2 in
“The best doctor gives the least medicines,” according to the scientist, Benjamin Franklin. In the 1700s, a patient only had one doctor and few medications available. Today, 67% of patients over the age of 60 consume five or more medications, including over-the-counter drugs and supplements. More doctors have implemented a new methodology to treating older Americans known as de-prescribing due to the rise of drug consumption, possible negative interactions, and increased risk of side effects.
America is home to just under 325 million people including a birth every 8 seconds, a death every 12 seconds and one international migrant every 28 seconds. At this moment, half of us have at least one chronic disease (40%), mental illness (18%) or drug/alcohol
As quality measurements define the Medicare space, quality is not as defined in the commercial markets. An area where PBMs do not have a concentrated focus is in medication management. Managing claims exposure means finding out why a pharmacy program is not controlling trend. One way to manage trend is to take an active role in monitoring and managing drug adherence and drug interactions that have a direct relation to the trend and the total rewards strategy.